by! The Herbal Working Group of the CAM Stakeholder Group !
Presenter: Robert Verkerk PhD - Alliance for Natural Health International!
Also on behalf of:
! EHTPA - European Herbal & Traditional Medicine Practitioners Association!
EITAM - European Initiative for Traditional Asian Medicine!

Use of herbals in the EU!

1st European Hearb Gathering

Market reports consistently show herbal medicine most popular form of complementary medicine used in Europe !
Germany and France = market leaders!

Herbal medicines widely used across the EU e.g. 2009 UK MHRA* showed that over a quarter of the UK population had used a herbal remedy in the previous 2 years !

Consumers relying on the legislators to provide them with a full range of traditional herbal medicines. Failure to achieve this will force consumers to buy from unreliable internet sources or back-street traders".

Original goal of THMPD: safe and ready access to traditional herbal medicinal products (THMPs) in the EU. To date only around 200 THMPs in 27 MSs registered since 2004.!
The THMPD has failed to provide for THMPs from systems of traditional medicine, such as Ayurveda (from the Indian subcontinent) or traditional Chinese medicine (TCM).!
THMPD does not clearly define the borderline between traditional herbal medicines and botanicals in food supplements!

More

In March 2014 EMA launched a pilot project to explore the adaptive pathways approach, a scientific concept of medicines development and data generation intended for medicines that address patients’ unmet medical needs.

Continue Reading

(2016/2057(INI) Committee on the Environment, Public Health and Food Safety
Rapporteur: Soledad Cabezón Ruiz

Download PDF

United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for New Deal to close the Health Innovation and Access Gap

Whether it’s the rising price of the EpiPen, or new outbreaks of diseases, like Ebola, Zika and yellow fever, the rising costs of health technologies and the lack of new tools to tackle health problems, like antimicrobial resistance, is a problem in rich and poor countries alike.

According to a High-Level Panel convened to advise the UN Secretary-General on improving access to medicines, the world must take bold new approaches to both health technology innovation and ensuring access so that all people can benefit from the medical advances that have dramatically improved the lives of millions around the world in the last century.